Holger Langhof

Access policies in biobank research: what criteria do they include and how publicly available are they? A cross-sectional study

Holger Langhof, Hannes Kahrass, Sören Sievers et al. · European Journal of Human Genetics · 2016 · 37 citations

Law, Health Policy, Clinical Research Regulation +7

Involving patients and the public in medical and health care research studies: An exploratory survey on participant recruiting and representativeness from the perspective of study authors

Jonas Lander, Holger Langhof, Marie‐Luise Dierks · PLoS ONE · 2019 · 33 citations · Full text

Public Health, Health Sciences, Community Engagement +16

Preclinical efficacy in therapeutic area guidelines from the U.S. Food and Drug Administration and the European Medicines Agency: a cross‐sectional study

Holger Langhof, William W. Chin, Susanne Wieschowski et al. · British Journal of Pharmacology · 2018 · 28 citations · Full text

Medicine, Pharmaceutical Policy, Pharmacology +13

Current practices for access, compensation, and prioritization in biobanks. Results from an interview study

Holger Langhof, Hannes Kahrass, Thomas Illig et al. · European Journal of Human Genetics · 2018 · 26 citations · Full text

Law, Health Information Management, Banking +9